Tuberculous pleurisy after tumour necrosis factor-a antagonist usage: Case report


Akoglu S., Babayigit C., Karazincir S., BALCI A., HANTA İ.

TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, cilt.56, sa.4, ss.448-452, 2008 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 56 Sayı: 4
  • Basım Tarihi: 2008
  • Dergi Adı: TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.448-452
  • Anahtar Kelimeler: Tumour necrosis factor, TNF antagonist, infliximab, tuberculosis
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

A thirty-six year old male patient presented with dyspnea, right-sided chest pain, night sweats and intermittent fever. He has a history of ankylosing spondylitis treated with tumour necrosis factor-alpha (TNF-alpha) antagonist (infliximab). Computed tomography of the chest showed mediastinal lymphadenopathy, right-sided pleural effusion, and atelectasis. The pleural fluid was exudative with lymphocyte dominance. Closed pleural biopsy was nondiagnostic. The adenosine deaminase level of the pleural fluid was 110 U/L. In light of these findings, the patient was diagnosed as tuberculous pleurisy and antituberculous treatment was given. After one month, pleural fluid was markedly reduced.